{"title":"A Comparative Study of Coronary Stent Utilization Pattern with respect to Coronary Stent Price Regulation: A hospital-based study from Mumbai, India","authors":"","doi":"10.37506/ijphrd.v14i4.19819","DOIUrl":null,"url":null,"abstract":"Introduction: India’s National Pharmaceutical and Pricing Authority (NPPA) fixed a ceiling price for coronarystents on 13th February 2017. In this study we compare the coronary stent usage patterns in a hospital in Indiabefore and after the coronary stent price regulation was implemented.Methodology: A retrospective cohort study at a private-sector tertiary care hospital among patients thatunderwent PCI from 13th February 2015 to 12th February 2019, i.e., two years before and after the priceregulation of coronary stents. Sampling was done by complete enumeration of the study population & thosefulfilling eligibility criteria. Data were collected from the hospital’s electronic health records and Cath-labregistry following the inclusion & exclusion criteria. Data on coronary stent utilization patterns were analyzedunder different subgroups using descriptive statistics. The Chi-square test was applied to assess statisticalsignificance. The results were considered significant when p value <0.05.Results: 1135 patients were included in the study of which 604 of them underwent PCI before the price regulationof coronary stents, and 531 after. 1154 and 1092 stents at an average of 1.91 and 2.05 stents were used per casebefore and after the price regulation respectively.Conclusion: The use of DES has increased after the coronary price regulation. Also, more third-generation DESwhich is the gold standard in coronary revascularization is being used compared to before. The use of superiorimported stents also saw an increase after the coronary price regulation. There was only a marginal increase instents used per case.","PeriodicalId":13368,"journal":{"name":"Indian Journal of Public Health Research and Development","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Public Health Research and Development","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37506/ijphrd.v14i4.19819","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: India’s National Pharmaceutical and Pricing Authority (NPPA) fixed a ceiling price for coronarystents on 13th February 2017. In this study we compare the coronary stent usage patterns in a hospital in Indiabefore and after the coronary stent price regulation was implemented.Methodology: A retrospective cohort study at a private-sector tertiary care hospital among patients thatunderwent PCI from 13th February 2015 to 12th February 2019, i.e., two years before and after the priceregulation of coronary stents. Sampling was done by complete enumeration of the study population & thosefulfilling eligibility criteria. Data were collected from the hospital’s electronic health records and Cath-labregistry following the inclusion & exclusion criteria. Data on coronary stent utilization patterns were analyzedunder different subgroups using descriptive statistics. The Chi-square test was applied to assess statisticalsignificance. The results were considered significant when p value <0.05.Results: 1135 patients were included in the study of which 604 of them underwent PCI before the price regulationof coronary stents, and 531 after. 1154 and 1092 stents at an average of 1.91 and 2.05 stents were used per casebefore and after the price regulation respectively.Conclusion: The use of DES has increased after the coronary price regulation. Also, more third-generation DESwhich is the gold standard in coronary revascularization is being used compared to before. The use of superiorimported stents also saw an increase after the coronary price regulation. There was only a marginal increase instents used per case.